Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Nov. 30, 2017 |
Nov. 30, 2016 |
Nov. 30, 2017 |
Nov. 30, 2016 |
Feb. 28, 2017 |
|
| Summary Of Significant Accounting Policies Details Narrative | |||||
| Sales tax receivables | $ 128,905 | $ 128,905 | $ 198,830 | ||
| Research and development expenses | $ 3,894,454 | $ 368,403 | 5,341,763 | $ 1,217,600 | |
| Grant revenue | 4,472 | ||||
| Research and development tax credit | $ 127,713 | ||||
| Warrants outstanding | 2,684,582 | 2,035,004 | 2,684,582 | 2,035,004 | |
| Common shares issuable | 1,000,000 | 1,000,000 | |||
| Restricted stock units, outstanding | 34,102 | ||||